Scientists reported Sunday they had found a plentiful source of stem cells in
the fluid that cushions babies in the womb and produced a variety of tissue
types from these cells - sidestepping the controversy over destroying
embryos for research.
 Dr. Anthony Atala, head of Wake Forest's regenerative
medicine institute, is photographed in his research lab at Piedmont Triad
Research Park in Winston-Salem, NC, Friday, Jan. 5, 2007. [AP]
 |
Researchers at Wake Forest
University and Harvard University reported the stem cells they drew from
amniotic fluid donated by pregnant women hold much the same promise as embryonic
stem cells. They reported they were able to extract the stem cells without harm
to mother or fetus and turn their discovery into several different tissue cell
types, including brain, liver and bone.
"Our hope is that these cells will provide a valuable resource for tissue
repair and for engineered organs as well," said Dr. Anthony Atala, head of Wake
Forest's regenerative medicine institute and senior researcher on the project.
It took Atala's team some seven years of research to determine the cells they
found were truly stem cells that "can be used to produce a broad range of cells
that may be valuable for therapy."
However, the scientists noted they still don't know exactly how many
different cell types can be made from the stem cells found in amniotic fluid.
They also said that even preliminary tests in patients are years away.
Still, Atala said the research reported in the scientific journal Nature
Biotechnology expands far beyond similar work discussed at a heart research
conference in November. There, Swiss researcher Simon Hoerstrup said he managed
to turn amniotic fluid stem cells into heart cells that could be grown into
replacement valves. Hoerstrup has yet to publish his work in a scientific
journal.
Atala said the new research has found even more promising stem cells with the
potential to turn into many more medically useful replacement parts.
"We have other cell lines cooking," Atala said.
The hallmark of human embryonic stem cells, which are created in the first
days after conception, is the ability to turn into any of the more than 220 cell
types that make up the human body. Researchers are hopeful they can train these
primordial cells to repair damaged organs in need of healthy cells.
However, many people, including President Bush, oppose the destruction of
embryos for any reason. The Bush administration has severely restricted federal
funding for the embryo work since 2001, leading many scientists to search for
alternative stem cell sources.
The cells from amniotic fluid "can clearly generate a broad range of
important cell types, but they may not do as many tricks as embryonic stem
cells," said Dr. Robert Lanza, chief scientist at the stem cell company Advanced
Cell Technology. "Either way, I think this work represents a giant step forward
for stem cell research."
It's the latest advance in the so-called regenerative medicine field that has
sprung from Atala's lab in Winston-Salem, N.C. In April, Atala and his
colleagues rebuilt bladders for seven young patients using live tissue grown in
the lab.
In the latest work, Atala's team extracted a small number of stem cells
swimming among the many other cell types in the amniotic fluid. One of the more
promising aspects of the research is that some of the DNA of the amnio stem
cells contained Y chromosomes, which means the cells came from the babies rather
than the pregnant moms.
Dr. George Daley, a Harvard University stem cell researcher, said that
finding raises the possibility that someday expectant parents can freeze amnio
stem cells for future tissue replacement in a sick child without fear of immune
rejection.
Nonetheless, Daley said the discovery shouldn't be used as a replacement for
human embryonic stem cell research.
"While they are fascinating subjects of study in their own
right, they are not a substitute for human embryonic stem cells, which allow
scientists to address a host of other interesting questions in early human
development," said Daley, who began work last year to clone human embryos to
produce stem cells.